Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Gets New President; TimeLogic Expands SAB

NEW YORK, Dec. 11-The bioinformatics company TimeLogic said yesterday that it had added Paragon Bioinformatics' Darrell Ricke to its scientific advisory board.

 

At Los Alamos National Laboratory, Ricke developed gene discovery software that helped identify the gene for Familial Mediterranean Fever.

 

He is currently bioinformatics director at Paragon.

 

TimeLogic is based in Crystal Bay, Nev.

 


 

Mark Emkjer has been appointed president of Accelrys, the software subsidiary of Pharmacopeia, the pharmaceutical company said on Dec. 9.

 

Emkjer was previously president and chief operating officer of Sunquest Information Systems, which provides information systems to hospitals, labs and clinics.

 


 

Klaus Schollmeier was named chief executive officer of Graffinity Pharmaceuticals by its supervisory board on Dec. 9.

 

Schollmeier was previously managing director of the healthcare/biotechnology group at ING-BHF Bank for ING Group Europe. Before that, he spent 16 years in pharmaceutical development at BASF.

 

Graffinity's core technology uses chemical microarrays to observe the interactions between compounds and protein drug targets. The company has partnerships with pharmaceutical companies and also plans to develop its own drug candidates.

 

Graffinity Pharmaceuticals is based in Heidelberg.

 


 

Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.